The major, N2-dG adduct of (+)-anti-B[a]PDE induces G-->A mutations in a 5'-AGA-3' sequence context.

Previously, in a random mutagenesis study, the (+)-anti diol epoxide of benzo[a]pyrene [(+)-anti-B[a]PDE] was shown to induce a complex mutational spectrum in the supF gene of an Escherichia coli plasmid, which included insertions, deletions and base substitution mutations, notably a significant fraction of GC-->TA, GC-->AT and GC-->CG mutations. At some sites, a single type of mutation dominated and to understand individual mutagenic pathways these sites were chosen for study by site-specific means to determine whether the major adduct, [+ta]-B[a]P-N2-dG, was responsible. [+ta]-B[a]P-N2-dG was shown to induce approximately 95% G-->T mutations in a 5'-TGC-3' sequence context and approximately 80% G-->A mutations in a 5'-CGT-3' sequence context. (+)-anti-B[a]PDE induced principally GC-->CG mutations in the G133 sequence context (5'-AGA-3') in studies using both SOS-uninduced or SOS-induced E. coli. Herein, [+ta]-B[a]P-N2-dG is shown to induce principally G-->A mutations (>90%) either without or with SOS induction in a closely related 5'-AGA-3' sequence context (identical over 7 bp). This is the first time that there has been a discrepancy between the mutagenic specificity of (+)-anti-B[a]PDE versus [+ta]-B[a]P-N2-dG. Eight explanations for this discordance are considered. Four are ruled out; e.g. the second most prevalent adduct [+ca]-B[a]P-N2-dG also induces a preponderance of G-->A mutations (>90%), so it also is not responsible for (+)-anti-B[a]PDE-induced G133-->C mutations. The four explanations not ruled out are discussed and include that another minor adduct might be responsible and that the 5'-AGA-3' sequence context differed slightly in the studies with [+ta]-B[a]P-N2-dG versus (+)-anti-B[a]PDE. In spite of the discordance, [+ta]-B[a]P-N2-dG induces G-->A mutations in the context studied herein and this result has proven useful in generating a hypothesis for what conformations of [+ta]-B[a]P-N2-dG are responsible for G-->T versus G-->A mutations.

[1]  R. Kozack,et al.  A hypothesis for what conformation of the major adduct of (+)-anti-B[a]PDE (N2-dG) causes G-->T versus G-->A mutations based upon a correlation between mutagenesis and molecular modeling results. , 1999, Carcinogenesis.

[2]  D. Jerina,et al.  Sequence context profoundly influences the mutagenic potency of trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-purine nucleoside adducts in site-specific mutation studies. , 1998, Biochemistry.

[3]  N. Geacintov,et al.  How stereochemistry affects mutagenesis by N2-deoxyguanosine adducts of 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene: configuration of the adduct bond is more important than those of the hydroxyl groups. , 1997, Biochemistry.

[4]  N. Geacintov,et al.  The major, N2-dG adduct of (+)-anti-B[a]PDE shows a dramatically different mutagenic specificity (predominantly, G --> A) in a 5'-CGT-3' sequence context. , 1997, Biochemistry.

[5]  S. Spiegel,et al.  Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2'-deoxyguanosine DNA adducts: marked effects of host cell, sequence context, and chirality. , 1996, Biochemistry.

[6]  E. Loechler.  The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems. , 1996, Carcinogenesis.

[7]  J. DiGiovanni,et al.  Targeted A --> T and G --> T mutations induced by site-specific deoxyadenosine and deoxyguanosine adducts, respectively, from the (+)-anti-diol epoxide of dibenz[a,j]anthracene in M13mp7L2. , 1996, Biochemistry.

[8]  N. Geacintov,et al.  The major, N2-Gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G-->A and G-->C, in addition to G-->T, mutations. , 1995, Biochemistry.

[9]  E. Loechler.  How are potent bulky carcinogens able to induce such a diverse array of mutations? , 1995, Molecular carcinogenesis.

[10]  R. Lloyd,et al.  In vivo and in Vitro Replication Consequences of Stereoisomeric Benzo[a]pyrene-7,8-dihydrodiol 9,10-Epoxide Adducts on Adenine N6 at the Second Position of N-ras Codon 61 (*) , 1995, The Journal of Biological Chemistry.

[11]  E. Loechler,et al.  The major, N2-Gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide can be unstable in double-stranded DNA. , 1995, Biochemistry.

[12]  N. Geacintov,et al.  Synthesis and characterization of covalent adducts derived from the binding of benzo[a]pyrene diol expoxide to a -GGG- sequence in a deoxyoligonucleotide. , 1995, Carcinogenesis.

[13]  R. Lloyd,et al.  The replication fate of R- and S-styrene oxide adducts on adenine N6 is dependent on both the chirality of the lesion and the local sequence context. , 1993, The Journal of biological chemistry.

[14]  J. DiGiovanni,et al.  Construction of Escherichia coli vectors containing deoxyadenosine and deoxyguanosine adducts from (+)-anti-dibenz[a,j]anthracene diol epoxide at a defined site. , 1993, Chemical research in toxicology.

[15]  R. Fuchs,et al.  Greater susceptibility to mutations in lagging strand of DNA replication in Escherichia coli than in leading strand. , 1993, Science.

[16]  E. Loechler,et al.  Mutational specificity of the (+)-anti-diol epoxide of benzo[a]pyrene in a supF gene of an Escherichia coli plasmid: DNA sequence context influences hotspots, mutagenic specificity and the extent of SOS enhancement of mutagenesis. , 1993, Carcinogenesis.

[17]  E. Loechler,et al.  Mutagenesis by the (+)-anti-diol epoxide of benzo[a]pyrene: what controls mutagenic specificity? , 1993, Biochemistry.

[18]  John Davis Groopman,et al.  The toxicology of aflatoxins: human health, veterinary and agricultural significance. , 1993 .

[19]  D. Eaton,et al.  8 – Mechanisms by Which Aflatoxins and Other Bulky Carcinogens Induce Mutations , 1993 .

[20]  J. DiGiovanni,et al.  Mutagenic specificity of the (+)anti‐diol epoxide of dibenz[a,j]anthracene in the supF gene of an Escherichia coli plasmid , 1993, Molecular carcinogenesis.

[21]  E. Loechler,et al.  An Escherichia coli plasmid-based, mutational system in which supF mutants are selectable: insertion elements dominate the spontaneous spectra. , 1992, Mutation research.

[22]  M. Benasutti,et al.  Mutagenesis by (+)-anti-B[a]P-N2-Gua, the major adduct of activated benzo[a]pyrene, when studied in an Escherichia coli plasmid using site-directed methods. , 1992, Carcinogenesis.

[23]  D. Jerina,et al.  Mutagenic specificities of four stereoisomeric benzo[c]phenanthrene dihydrodiol epoxides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Geacintov,et al.  Spectroscopic characteristics and site I/site II classification of cis and trans benzo[a]pyrene diolepoxide enantiomer-guanosine adducts in oligonucleotides and polynucleotides. , 1991, Carcinogenesis.

[25]  D. Jerina,et al.  Covalent nucleoside adducts of benzo[a]pyrene 7,8-diol 9,10-epoxides: structural reinvestigation and characterization of a novel adenosine adduct on the ribose moiety , 1991 .

[26]  N. Geacintov,et al.  Preparation and isolation of adducts in high yield derived from the binding of two benzo[a]pyrene-7,8-dihydroxy-9,10-oxide stereoisomers to the oligonucleotide d(ATATGTATA). , 1990, Carcinogenesis.

[27]  R. Rill,et al.  Sequence preferences of covalent DNA binding by anti-(+)- and anti-(-)-benzo[a]pyrene diol epoxides. , 1990, Biochemistry.

[28]  A. Wolfe,et al.  The formation of covalent adducts between benzo[a]pyrenediol epoxide and RNA: structural analysis by mass spectrometry. , 1990, Biochemistry.

[29]  J. M. Roman,et al.  DNA adducts from carcinogenic and noncarcinogenic enantiomers of benzo[a]pyrene dihydrodiol epoxide. , 1989, Chemical research in toxicology.

[30]  M. Benasutti,et al.  Construction of an Escherichia coli vector containing the major DNA adduct of activated benzo[a]pyrene at a defined site. , 1988, Chemical research in toxicology.

[31]  H. Masukata,et al.  Control of primer formation for ColE1 plasmid replication: Conformational change of the primer transcript , 1986, Cell.

[32]  W. Haseltine,et al.  High ratio of alkali-sensitive lesions to total DNA modification induced by benzo(a)pyrene diol epoxide. , 1984, The Journal of biological chemistry.

[33]  H. Masukata,et al.  Effects of point mutations on formation and structure of the RNA primer for ColE1 DNA replication , 1984, Cell.

[34]  T. Itoh,et al.  Inhibition of ColE1 RNA primer formation by a plasmid-specified small RNA. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Osborne,et al.  The in vitro and in vivo reaction at the N7-position of guanine of the ultimate carcinogen derived from benzo[a]pyrene , 1979 .

[36]  A. Burlingame,et al.  Identification of the major adducts formed by reaction of benzo(a)pyrene diol epoxide with DNA in vitro. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Harris,et al.  Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. , 1976, Science.